Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bobby Thomas

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
ACS Chemical Neuroscience|January 18, 2018
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsIrina N Gaisina, Sue H Lee, Navneet A Kaidery, et al.
Aging and Disease|January 6, 2017
Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson's DiseaseNatalya A Smirnova, Navneet Ammal Kaidery, Dmitry M Hushpulian, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2025
Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesisSuwarna Chakraborty, Sunil Jamuna Tripathi, Edwin Vázquez-Rosa, et al.
Human Molecular Genetics|June 4, 2018
Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathyVictor Tapias, Shari Jainuddin, Manuj Ahuja, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase InhibitorsAndrey A Poloznikov, Sergey V Nikulin, Dmitry M Hushpulian, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2025
Biliverdin reductase A is a major determinant of protective NRF2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Redox Biology|August 8, 2025
Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseasesDmitry M Hushpulian, Navneet Ammal Kaidery, Priyanka Soni, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASESDmitry M Hushpulian, Navneet Ammal Kaidery, Priyanka Soni, et al.
Plos One|April 16, 2011
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2David Ramonet, João Paulo L Daher, Brian M Lin, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
ACS Chemical Neuroscience|January 18, 2018
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsIrina N Gaisina, Sue H Lee, Navneet A Kaidery, et al.
Aging and Disease|January 6, 2017
Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson's DiseaseNatalya A Smirnova, Navneet Ammal Kaidery, Dmitry M Hushpulian, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2025
Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesisSuwarna Chakraborty, Sunil Jamuna Tripathi, Edwin Vázquez-Rosa, et al.
Human Molecular Genetics|June 4, 2018
Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathyVictor Tapias, Shari Jainuddin, Manuj Ahuja, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase InhibitorsAndrey A Poloznikov, Sergey V Nikulin, Dmitry M Hushpulian, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2025
Biliverdin reductase A is a major determinant of protective NRF2 signalingChirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
Redox Biology|August 8, 2025
Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseasesDmitry M Hushpulian, Navneet Ammal Kaidery, Priyanka Soni, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASESDmitry M Hushpulian, Navneet Ammal Kaidery, Priyanka Soni, et al.
Plos One|April 16, 2011
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2David Ramonet, João Paulo L Daher, Brian M Lin, et al.
Pageof 7